Laboratory of Radiochemistry
LRC
The Laboratory of Radiochemistry focuses on fundamental research and on education in the field of radiochemistry. The three research groups explore the chemistry of heavy elements, study the radionuclide inventory in beam targets of large scale irradiation facilities, provide novel radionuclides for future medical applications, and investigate the chemical behaviour of radionuclides in liquid metals proposed as target material or coolant in future nuclear facilities.
The LRC encompasses the following Research Groups:
Heavy Elements
Development of fast chemical methods for the investigation of superheavy elements. We perform radiochemical studies with the heaviest elements of the periodic table. This research focuses on the investigation of deviations of chemical properties induced by the high nuclear charge in the atoms of the superheavy elements. The developed methods are instrumental to the discovery of new isotopes of superheavy elements and to the determination of their nuclear decay properties.
More information about Heavy Elements (PSI)
More information about Heavy Elements (PSI)
Isotope and Target Chemistry ITC
Investigation and exploitation of activated material. Isotope and Target Chemistry (ITC) is a research group that deals not only with the study of the radioactive content of activated material and the physico-chemical behaviour of radionuclides therein, but is also focused on separation of rare exotic radionuclides needed in different scientific research fields like astrophysics, environmental research, fundamental nuclear physics and others.
More information about Isotope and Target Chemistry (PSI)
More information about Isotope and Target Chemistry (PSI)
Radionuclide Development
Development of radionuclides for innovative radiopharmaceuticals. Using PSI's cyclotrons and spallation neutron source (SINQ), the joint group of LCH and CRS provides novel, commercially not available radionuclides for future diagnosis and therapy of cancer, which, subsequently, are tested in pre-clinical trials.
More information about Radionuclide Development (PSI)
More information about Radionuclide Development (PSI)